Helix BioPharma Corp.: Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period

RICHMOND HILL, ON / ACCESSWIRE / March 11, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology

Related Keywords

Canada ,Toronto ,Ontario ,Richmond Hill ,Canadian ,Frank Michalargias ,Alpha Bronze ,Toronto Stock Exchange ,Helix Biopharma Corp ,Incentive Program ,Helix Biopharma ,Incentive Plan ,Jerzy Wilczewski ,Interim Chief Executive ,Multilateral Instrument ,Minority Security Holders ,Special Transactions ,Eligible Warrants ,Incentive Exercise Price ,Extended Warrants ,Warrant Extension ,Chief Financial ,Looking Statements ,Chief Executive ,Annual Information Form ,Helix ,Iopharma ,Orp ,Loses ,Private ,Placement ,Nnounces ,Early ,Warrant ,Exercise ,Incentive ,Program ,Extension ,Eriod ,